![]() | |||||||||||||||||||||||||||||||||||||
Study Finds That PReP Acceptance Depends on Cost Instead of EffectivenessBy Candace Y.A. Montague June 8, 2011
A study out of UCLA and Lima, Peru show that people are more willing to use Truvada, the anti-retroviral drug for HIV, if they can pay less money for it regardless of its effectiveness. The International Study of STD and AIDS published the results of the study last week. Using consumer marketing techniques, the study found that female sex workers, male-to-female transgender persons and men who have sex with men would be willing to take the pill if the cost to purchase it was low. The participants also said that they would be willing to take the pill if it were 100 percent effective and only required to be taken right before sex. The results from the scientific research published earlier this year showed that in order for the pill to be effective, participants would have to take it daily regardless of sexual activity and it only cuts the risk of infection by 44%. These expectations are not surprising to this Examiner who wondered about the cost of this treatment in an earlier report. Health educators want to have effective treatment that would in fact prevent HIV transmission. But out-of-pocket cost has a direct effect on accessibility. If a person wants to protect themselves from contracting the virus, chances are they will not spend more than what they do on a three pack of condoms to get that protection. It's just not feasible. Other factors weighed in on the participants willingness to use PReP including where they would be willing to go to pick up the pill, side effects, and the duration of use. Health care must be made more affordable and more opportune on all levels if we expect to stop the virus. For more information about the study click here. Get e-mail notifications every time Candace's blog is updated.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
BLOG:
D.C. HIV/AIDS Examiner ![]() Candace Y.A. Montague Candace Y.A. Montague has been learning about HIV since 1988 (and she has the certificates from the American Red Cross to prove it). Health is a high priority to Candace because she believes that nothing can come of your life if you're not healthy enough to enjoy it. One of her two master's degrees is in Community Health Promotion and Education. Candace was inspired to act against HIV after seeing a documentary in 2008 about African-American women and HIV. She knew that writing was the best way for her to make a difference and help inform others. Candace is a native Washingtonian and covers HIV news all around D.C. She has covered fundraisers, motorcycle rides, town hall meetings, house balls, Capitol Hill press conferences, election campaigns and protests for The DC Examiner.com and emPower News Magazine. Subscribe to Candace's Blog:
Recent Posts:
April 5, 2013 - The Sexual Health Lessons of Tyler Perry's Tempation: A Blog Entry by Candace Y.A. Montague
March 25, 2013 - Candace's AIDS News Update: A Blog Entry by Candace Y.A. Montague March 11, 2013 - Three Condoms Rule No More: A Blog Entry by Candace Y.A. Montague March 5, 2013 - HIV Prevention Strategies for Women Proven Ineffective: A Blog Entry by Candace Y.A. Montague February 8, 2013 - Black HIV/AIDS Awareness: Eight Points to Keep in Mind A Brief Disclaimer: The opinions expressed by TheBody.com's bloggers are entirely their own, and do not necessarily reflect the views of TheBody.com itself. |
|
|||||||||||||||||||||||||||||||||||